Modifications of p53 and the DNA damage response in cells expressing mutant form of the protein huntingtin

Journal of Molecular Neuroscience

Volumn 45, Issue 2, 2011, Pages 256-268

  Illuzzi, Jennifer L ^a,b   Vickers, Cassie A ^a   Kmiec, Eric B ^a  

^a MARSHALL UNIVERSITY   (United States)

^b UNIVERSITY OF DELAWARE   (United States)

Author keywords

DNA damage; Huntingtin; Huntington's disease; p53

Indexed keywords

HUNTINGTIN; MUTANT PROTEIN; PROTEIN MDM2; PROTEIN P300; PROTEIN P53;

ACETYLATION; ARTICLE; CELL STRAIN HEK293; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DNA DAMAGE; EMBRYO; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; INTRACELLULAR SIGNALING; OLIGOMERIZATION; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; UBIQUITINATION;

ANIMALS; DNA DAMAGE; HEK293 CELLS; HUMANS; HUNTINGTON DISEASE; MUTATION; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PEPTIDE FRAGMENTS; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITINATION;

EID: 80054883676     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-011-9516-4     Document Type: Article

References (60)

1. M Ahn M Urist C Prives 2004 The Chk2 protein kinase DNA Repair 3 1039 1047 15279791 10.1016/j.dnarep.2004.03.033 1:CAS:528:DC%2BD2cXmtVeqt7s%3D (Pubitemid 38997946)
2. E Appella CW Anderson 2001 Post-translational modifications and activation of p53 by genotoxic stresses Eur J Biochem 268 2764 2772 11358490 10.1046/j.1432-1327.2001.02225.x 1:CAS:528:DC%2BD3MXktVSktr8%3D (Pubitemid 32862957)
3. L Arning PH Kraus C Saft J Andrich JT Epplen 2005 Age of onset of Huntington disease is not modulated by the R72P variation in TP53 and the R196K variation in the gene coding for the human caspase activated DNase (hCAD) BMC Med Genet 6 35 37 16202123 10.1186/1471-2350-6-35 (Pubitemid 41554975)
4. CJ Bakkenist MB Kastan 2003 DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation Nature 421 499 506 12556884 10.1038/nature01368 1:CAS:528:DC%2BD3sXntFSqsQ%3D%3D (Pubitemid 36168436)
5. S Banin L Moyal S Shieh Y Taya CW Anderson L Chessa NI Smorodinsky C Prives Y Reiss Y Shiloh Y Ziv 1998 Enhanced phosphorylation of p53 by ATM in response to DNA damage Science 281 1674 1677 9733514 10.1126/science.281.5383. 1674 1:CAS:528:DyaK1cXmtVKitLY%3D (Pubitemid 28435583)
6. CL Brooks W Gu 2003 Ubiquitination, phosphorylation, and acetylation: the molecular basis of p53 regulation Curr Opin Cell Biol 15 165 171 10.1016/S0955-0674(03)00003-6 (Pubitemid 36332191)
7. S Carter KH Vousden 2009 Modifications of p53: competing for the lysines Curr Opin Genet Development 19 18 24 10.1016/j.gde.2008.11.010 1:CAS:528:DC%2BD1MXisFKnsrc%3D
8. B Chattopadhyay K Baksi S Mukhopadhyay NP Bhattacharyya 2005 Modulation of age of onset of Huntington's disease patients by variations in TP53 and human caspase activated DNase (hCAD) genes Neurosci Lett 2 81 86 10.1016/j.neulet. 2004.10.018 (Pubitemid 40092201)
9. NH Chehab A Malikzay ES Stavridi TD Halazonetis 1999 Phosphorylation of ser-20 mediates stabilization of human p53 in response to DNA damage Proc Natl Acad Sci 96 13777 13782 10570149 10.1073/pnas.96.24.13777 1:CAS:528: DyaK1MXns1Oqt74%3D
10. S Cong BA Pepers BO Evert DC Rubinsztein RA Roos GJ van Ommen JC Dorsman 2005 Mutant huntingtin represses CBP, but not p300, by binding and protein degradation Mol Cell Neurosci 30 12 23 15994095 10.1016/j.mcn.2005.05.003 1:CAS:528:DC%2BD2MXnslyjurY%3D (Pubitemid 41133336)
11. M DiFiglia E Sapp K Chase C Schwarz A Meloni C Young E Martin JP Vonsattel R Carraway SA Reeves FM Boyce N Aronin 1995 Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons Neuron 14 1075 1081 7748555 10.1016/0896-6273(95)90346-1 1:CAS:528: DyaK2MXlsl2hsLs%3D
12. CM Eischen G Lozano 2009 p53 and MDM2: antagonists or partners in crime? Cancer Cell Previews 15 161 162 10.1016/j.ccr.2009.02.004 1:CAS:528: DC%2BD1MXltFSmtb4%3D
13. Y Enokido T Tamura H Ito A Arumughan A Komuro H Shiwaku M Sone R Foulle H Sawada H Ishiguro T Ono M Murata I Kanazawa N Tomilin K Tagawa EE Wanker H Okazawa 2010 Mutant huntingtin impairs Ku70-mediated DNA repair J Cell Biol 189 425 443 20439996 10.1083/jcb.200905138 1:CAS:528:DC%2BC3cXlvFyhtLc%3D
14. JM Espinosa RE Verdun BM Emerson 2003 p53 functions through stress- and promoter-specific recruitment of transcription initiation components before and after DNA damage Mol Cell 12 1015 1027 14580351 10.1016/S1097-2765(03)00359-9 1:CAS:528:DC%2BD3sXovVKjurk%3D (Pubitemid 37352792)
15. Z Feng S Jin A Zupnick J Hoh E de Stanchina S Lowe C Prives AJ Levine 2006 p53 tumor suppressor protein regulates the levels of huntingtin gene expression Oncogene 25 1 7 16278683 10.1038/sj.onc.1209551 (Pubitemid 43980476)
16. DA Freedman AJ Levine 1998 Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6 Mol Cell Biol 18 7288 7293 9819415 1:CAS:528:DyaK1cXnvVKlurk%3D (Pubitemid 28533048)
17. JD Godin K Colombo M Molina-Calavita G Keryer D Zala BC Charrin P Dietrich ML Volvert F Guillemot I Dragatsis Y Bellaiche F Saudou L Nguyen S Humbert 2010 Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis Cell 67 392 406 1:CAS:528:DC%2BC3cXpvFWisLc%3D
18. W Gu RG Roeder 1997 Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain Cell 90 595 606 9288740 10.1016/S0092-8674(00)80521-8 1:CAS:528:DyaK2sXlvFKmtLc%3D (Pubitemid 27357952)
19. PS Harper 1999 Huntington's disease: a clinical, genetic, and molecular model for polyglutamine repeat disorders Philos Trans R Soc Lond B Biol Sci 354 957 961 10434293 10.1098/rstb.1999.0446 1:CAS:528:DyaK1MXltVWrtr8%3D
20. G Hoffner P Kahlem P Djian 2002 Perinuclear localization of huntingtin as a consequence of its binding to microtubules through an interaction with B-tubulin: relevance to Huntington's disease J Cell Sci 115 941 948 11870213 1:CAS:528:DC%2BD38Xitl2rtLw%3D (Pubitemid 34257379)
21. R Honda H Tanaka H Yasuda 1997 Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 FEBS Lett 420 25 27 9450543 10.1016/S0014-5793(97) 01480-4 1:CAS:528:DyaK2sXotVyjtrg%3D (Pubitemid 28037193)
22. Huntington's Disease Collaborative Research Group 1993 A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosome Cell 72 971 983 10.1016/0092-8674(93)90585-E (Pubitemid 23110238)
23. J Illuzzi S Yerkes H Parekh-Olmedo EB Kmiec 2009 DNA damage response proteins precede the appearance of visible mutant huntingtin aggregate J Neurosci Res 87 733 747 18831068 10.1002/jnr.21881 1:CAS:528: DC%2BD1MXit1Whsrs%3D
24. Y Itahana H Ke Y Zhang 2009 p53 oligomerization is essential for its C-terminal lysine acetylation J Biol Chem 281 5158 5164
25. H Jiang MA Poirier Y Liang Z Pei CE Wiskittel WW Smith DB DeFranco CA Ross 2006 Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin Neurobiol Dis 23 543 551 16766198 10.1016/j.nbd.2006.04.011 1:CAS:528:DC%2BD28XotlWnsLY%3D (Pubitemid 44234090)
26. Y Kawaguchi A Ito E Appella T Yao 2006 Charge modifications at multiple C-terminal lysine residues regulates p53 oligomerization and its nucleus-cytoplasm trafficking J Biol Chem 281 1394 1400 16291740 10.1074/jbc.M505772200 1:CAS:528:DC%2BD28XksFOgtA%3D%3D
27. SE Kern KW Kinzler A Bruskin D Jarosz P Friedman C Prives B Vogelstein 1991 Identification of p53 as a sequence-specific DNA binding protein Science 252 1708 1711 2047879 10.1126/science.2047879 1:CAS:528:DyaK3MXkvVKmurs%3D (Pubitemid 21917093)
28. SH Li AL Cheng H Zhou S Lam M Rao H Li XJ Li 2002 Interaction of Huntington disease protein with the transcriptional activator Sp1 Mol Cell Biol 22 1277 1287 11839795 10.1128/MCB.22.5.1277-1287.2002 1:CAS:528: DC%2BD38XhtlKgsbc%3D (Pubitemid 34150765)
29. M Li CL Brooks F Wu-Baer D Chen R Baer W Gu 2003 Mono- versus polyubiquitination: differential control of p53 fate by MDM2 Science 302 1972 1975 14671306 10.1126/science.1091362 1:CAS:528:DC%2BD3sXps1amsLw%3D (Pubitemid 37523506)
30. L Liu D Scolnick R Trievel H Zhang R Marmorstein T Halazonetis S Berger 1999 p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage Mol Cell Biol 19 1202 1209 9891054 1:CAS:528: DyaK1MXhtVKhtro%3D (Pubitemid 29046862)
31. Y Liu SE Elf Y Miyata G Sashida Y Liu G Huang S DiGiandomenico JM Lee A Deblasio S Menendez J Antipin B Reva A Koff SD Nimer 2009 p53 regulates hematopoietic stem cell quiescence Cell Stem Cell 4 37 48 19128791 10.1016/j.stem.2008.11.006 1:CAS:528:DC%2BD1MXhtVSks78%3D
32. N Marchenko S Wolff S Erster K Becker U Moll 2007 Monoubiquitylation promotes mitochondrial p53 translocation EMBO J 26 923 934 17268548 10.1038/sj.emboj.7601560 1:CAS:528:DC%2BD2sXhvFWksrs%3D
33. J Marine S Francoz M Maetens G Wahl F Toledo G Lozano 2006 Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4 Cell Death Differ 13 927 934 16543935 10.1038/sj.cdd.4401912 1:CAS:528:DC%2BD28Xks1Ortbo%3D
34. K Meletis V Wirta SM Hede M Nister J Lundeberg J Frisen 2006 p53 suppresses the self-renewal of adult neural stem cells Development 133 363 369 16368933 10.1242/dev.02208 1:CAS:528:DC%2BD28XhsFamsrk%3D (Pubitemid 43210724)
35. D Menendez A Inga MA Resnick 2009 The expanding universe of p53 targets Nature 9 724 737 1:CAS:528:DC%2BD1MXhtFKmsb7M
36. D Michael M Oren 2003 The p53-Mdm2 module and the ubiquitin system Semin Cancer Biol 13 49 58 12507556 10.1016/S1044-579X(02)00099-8 1:CAS:528: DC%2BD38XpvVWksrw%3D (Pubitemid 36269180)
37. N Minksy M Oren 2004 The RING domain of Mdm2 mediates histone ubiquitylation and transcriptional repression Mol Cell 16 631 639 10.1016/j.molcel.2004.10.016 (Pubitemid 39531885)
38. J Momand GP Zambetti DC Olson D George AJ Levine 1992 The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation Cell 69 1237 1245 1535557 10.1016/0092-8674(92)90644-R 1:CAS:528:DyaK3sXit1Ogs7o%3D
39. JD Oliner JA Pietenpol S Thiagalingam J Gyuris KW Kinzler B Vogelstein 1993 Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 Nature 362 857 860 8479525 10.1038/362857a0 1:CAS:528:DyaK3sXkt1ait7g%3D (Pubitemid 23132165)
40. JA Pietenpol T Tokino S Thaigalingam WS el-Diery KW Kinzler B Vogelstein 1994 Sequence-specific transcriptional activation is essential for growth suppression by p53 PNAS 91 1998 2002 8134338 10.1073/pnas.91.6.1998 1:CAS:528:DyaK2cXivFWgs7c%3D (Pubitemid 24092029)
41. I Pires T Ward C Dive 2010 Oxaliplatin responses in colorectal cancer cells are modulated by CHK2 kinase inhibitors Br J Pharmacol 159 1326 1338 20128802 10.1111/j.1476-5381.2009.00607.x 1:CAS:528:DC%2BC3cXjs1ektbc%3D
42. C Prives PA Hall 1999 The p53 pathway J Pathol 187 112 126 10341712 10.1002/(SICI)1096-9896(199901)187:1<112::AID-PATH250>3.0.CO;2-3 1:CAS:528:DyaK1MXmvVKrtQ%3D%3D (Pubitemid 29009841)
43. S Rega T Stiewe DI Chang B Pollmeir H Esche W Bardenheuer G Marquitan BM Putzer 2001 Identification of the full-length huntingtin-interacting protein p231HBP/HYBP as a DNA-binding factor Mol Cell Neurosci 18 68 79 11461154 10.1006/mcne.2001.1004 1:CAS:528:DC%2BD3MXlt1Cmuro%3D (Pubitemid 32695193)
44. EP Rogakou DR Pilch AH Orr VS Ivanova WM Bonner 1998 DNA double-strand breaks induce histone H2AX phosphorylation on serine 139 J Biol Chem 273 5858 5868 9488723 10.1074/jbc.273.10.5858 1:CAS:528:DyaK1cXhsleiu7g%3D (Pubitemid 28124064)
45. J Roth M Dobbelstein D Freedman T Shenk AJ Levine 1997 Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein Eur Mol Biol Organization 17 554 564 10.1093/emboj/17.2.554 (Pubitemid 28045495)
46. K Sakaguchi J Herrera S Saito T Miki M Bustin A Vassilev C Anderson E Appella 1998 DNA damage activates p53 through a phosphorylation-acetylation cascade Genes Dev 12 2831 2841 9744860 10.1101/gad.12.18.2831 1:CAS:528:DyaK1cXmtFCkurk%3D (Pubitemid 28440142)
47. A Sancar LA Lindsey-Boltz K Unsal-Kacmaz S Linn 2004 Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints Annu Rev Biochem 73 39 85 15189136 10.1146/annurev.biochem.73.011303.073723 1:CAS:528: DC%2BD2cXmslagsrk%3D (Pubitemid 39050363)
48. JS Steffan N Agrawal J Pallos E Rockabrand LC Trotman N Slepko K Illes T Lukacsovich YZ Zhu E Cattaneo PP Pandolfi LM Thompson JL Marsh 2004 SUMO modification of huntingtin and Huntington's disease pathology Science 304 100 104 15064418 10.1126/science.1092194 1:CAS:528:DC%2BD2cXis1ansLs%3D (Pubitemid 38451465)
49. RV Sionov Y Haupt 1999 The cellular response to p53: the decision between life and death Oncogene 18 6145 6157 10557106 10.1038/sj.onc.1203130 1:CAS:528:DyaK1MXns1Oqs7w%3D
50. GC Smith RB Cary ND Lakin BC Hann SH Teo DJ Chen SP Jackson 1999 Purification of DNA binding properties of ataxia-telangiectasia gene product ATM Proc Natl Acad Sci 96 11134 11139 10500142 10.1073/pnas.96.20.11134 1:CAS:528:DyaK1MXmvVCnu74%3D (Pubitemid 29487346)
51. DP Teufel SM Freund M Bycroft AR Fersht 2007 Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53 Proc Natl Acad Sci 104 7009 7014 17438265 10.1073/pnas.0702010104 1:CAS:528:DC%2BD2sXls1Oktb4%3D (Pubitemid 47186000)
52. E Trushina RB Dyer JDII Badger D Ure L Eide DD Tran BT Vrieze V Legendre-Guillemin PS McPherson BS Mandavilli B Van Houten S Zeitlin M McNiven R Aebersold M Hayden JE Parisi E Seeberg I Dragatsis K Doyle A Bender C Chacko CT McMurray 2004 Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro Mol Cell Biol 24 8195 8209 15340079 10.1128/MCB.24.18. 8195-8209.2004 1:CAS:528:DC%2BD2cXnslCrsbY%3D (Pubitemid 39167467)
53. KH Vousden DP Lane 2007 p53 in health and disease Nat Rev Mol Cell Biol 8 275 283 17380161 10.1038/nrm2147 1:CAS:528:DC%2BD2sXjtlygsr0%3D (Pubitemid 46474662)
54. GM Wahl 2006 Mouse bites dogma: how mouse models are changing our views of how p53 is regulated in vivo Cell Death Differ 13 973 983 16575406 10.1038/sj.cdd.4401911 1:CAS:528:DC%2BD28Xks1Ortb0%3D
55. L Wang Y Tang PA Cole R Marmorstein 2008 Structure and chemistry of the p300/CBP and Rtt109 histone acetyltransferases: implications for histone acetyltranferase evolution and function Curr Opin Struct Biology 18 741 747 10.1016/j.sbi.2008.09.004 1:CAS:528:DC%2BD1cXhsVOisr%2FI
56. MJF Waterman ES Stavridi JLF Waterman TD Halazonetis 1998 ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins Nat Genet 19 175 178 9620776 10.1038/542 1:CAS:528:DyaK1cXls1Cru7Y%3D (Pubitemid 28248801)
57. M Wells 2008 Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain PNAS 105 5762 5767 18391200 10.1073/pnas.0801353105 1:CAS:528:DC%2BD1cXltFShsLY%3D (Pubitemid 351758446)
58. S Wu C Chiang 2009 Crosstalk between sumoylation and acetylation regulates p53-dependent chromatin transcription and DNA binding EMBO J 28 1246 1259 19339993 10.1038/emboj.2009.83 1:CAS:528:DC%2BD1MXjvV2ksrs%3D
59. W Zhai H Jeong L Cui D Krainc R Tjian 2005 In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets Cell 123 1241 1253 16377565 10.1016/j.cell.2005.10.030 1:CAS:528:DC%2BD28XktlWitg%3D%3D (Pubitemid 41821782)
60. Y Zhang Y Xiong 2001 A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation Science 292 1910 1915 11397945 10.1126/science.1058637 1:CAS:528:DC%2BD3MXksVaqurs%3D (Pubitemid 32538366)